Skip to content

Drug interactions

Nilotinib + Rifabutin

Severity: Major

Nilotinib and Rifabutin: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Rifabutin induces CYP3A4 and can lower nilotinib concentrations, risking treatment failure in leukemia. The inducing effect is weaker than that of rifampicin but still potentially relevant.

What this interaction means in plain words

Nilotinib and Rifabutin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Nilotinib belongs to Oncology; Rifabutin belongs to Anti Bacterial.

Evidence level: Moderate

Why it happens

Induction of CYP3A4 by rifabutin increases nilotinib metabolism and lowers its exposure.

What to do

Avoid the combination and consider an alternative antimycobacterial. If it is unavoidable, monitor response and consider nilotinib dose adjustment with ECG monitoring.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nilotinib and Rifabutin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Nilotinib with Rifabutin?

MediHelp rates the interaction as major. Nilotinib and Rifabutin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Rifabutin induces CYP3A4 and can lower nilotinib concentrations, risking treatment failure in leukemia. The inducing effect is weaker than that of rifampicin but still potentially relevant.

How serious is the interaction between Nilotinib and Rifabutin?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination and consider an alternative antimycobacterial. If it is unavoidable, monitor response and consider nilotinib dose adjustment with ECG monitoring.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in